FDA considers adding a dozen peptides to its bulk drug compounding list RAPS BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved FDA Peptide Category 2 Removal & Public Meeting July 23rd Mansi Hukmani posted on the topic LinkedIn RFK Jr. & claimed regenerative peptides like BPC 157 The Niche